A
Astrana Health, Inc.
ASTH · NASDAQ · Healthcare · 2.0B
Price · close
$39.35
+1.57% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
85.9×
Price / net assetsP/B
3.5×
Enterprise value / EBITDAEV/EBITDA
19.1×
Free cash flow yieldFCF yield
5.4%
Return on equityROE
2.9%
Operating margin
2.5%
Net debt / EBITDAbalance-sheet strength
4.8×
Interest coverage
1.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.